Published in Cancer Weekly, September 25th, 2001
J.J. Kim and colleagues at the University of Pennsylvania previously reported on the use of a DNA vaccine that encodes for human PSA to elicit host immune responses against cells producing PSA. Here, they examined immune responses and safety profiles in macaques immunized with DNA-based PSA vaccine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.